OpenVSafe by OpenVAERS
Search V-safe

79H-55213-74298

2 vaccinations 5 coded responses 24 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
937 / CA
Registered
2021-01-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-18
    Registered in v-safe
  2. 2021-01-18
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-18
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-25
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-08
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-08
    Health check-in — day 0, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  13. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Chills, Muscle or body aches
    Adult check-in
  14. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  15. 2021-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Itching · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-02-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood glucose increased, Decreased appetite — Feeling: Good · Site: Itching · Joint pains
    Free text: Lack of appetite, which has caused elevated blood sugar.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Asthenia, Dyspnoea — Feeling: Good · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: It's only when I wake up, and for a few hours. At that point, I'm just trying to breathe and not feel so weak.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-02-15
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-02-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-10
    Survey response — 3 months, dose 2
    MedDRA: Blood glucose increased — Feeling: Good
    Free text: Increased numbers when doing a glucose test, and despite medication, exercise and diet, the numbers aren't going down.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-08-09
    Survey response — 6 months, dose 2
    MedDRA: Blood glucose increased, Blood pressure increased, Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: My blood sugar has remained elevated, as has my blood pressure. They were under control until I had the vaccines.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  27. 2022-02-08
    Survey response — 12 months, dose 2
    MedDRA: Taste disorder — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Sensitivity to taste.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-18Pfizer-BioNTech
22021-02-08Pfizer-BioNTech

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-12

Systemic reaction (other): Lack of appetite, which has caused elevated blood sugar.

2021-02-13

Systemic reaction (other): It's only when I wake up, and for a few hours. At that point, I'm just trying to breathe and not feel so weak.

Release 8 — 3 months, dose 2

2021-05-10

Symptoms: Increased numbers when doing a glucose test, and despite medication, exercise and diet, the numbers aren't going down.

Release 9 — 6 months, dose 2

2021-08-09

Symptoms: My blood sugar has remained elevated, as has my blood pressure. They were under control until I had the vaccines.

Release 11 — 12 months, dose 2

2022-02-08

Symptoms: Sensitivity to taste.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBlood glucose increased ✓ ✓ ✓
SDBlood pressure increased ✓ · ✓
SDCondition aggravated ✓ · ✓
SDPre-existing disease ✓ · ✓
SDTaste disorder · · ✓
SROAsthenia ✓ ✓ ✓
SROBlood glucose increased ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release